AbbVie is a Dividend King, poised for strong growth with Rinvoq and Skyrizi. Eli Lilly has taken control of the obesity drug market, with major possibilities ahead.
Source: https://www.fool.com/investing/2026/02/19/3-stocks-to-buy-an…
Microsoft has reached lows not seen in some time. Alphabet has given back some of its gains.
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Broadcom has a massive opportunity ahead with custom AI chips. UiPath has huge potential upside as its revenue starts to accelerate.
